Dr. Laurel Karian Chandler, MD Surgery - Plastic and Reconstructive Surgery Medicare: Accepting Medicare Assignments Practice Location: 53 Old Kings Hwy N Ste 205, Darien, CT 06820 Phone: 978-460-0211 |
Dr. Jonathan Norton Bowman, M.D. Surgery - Vascular Surgery Medicare: Accepting Medicare Assignments Practice Location: 85 Old Kings Hwy N, Darien, CT 06820 Phone: 203-210-6333 Fax: 203-502-2615 |
Dr. Ben U. Marsan, M.D. Surgery - Vascular Surgery Medicare: Accepting Medicare Assignments Practice Location: 85 Old Kings Hwy N, Darien, CT 06820 Phone: 203-956-6819 Fax: 203-425-2795 |
Dr. Saul Asken, M.D. Surgery - Plastic and Reconstructive Surgery Medicare: Not Enrolled in Medicare Practice Location: 484 Post Rd, Darien, CT 06820 Phone: 203-662-9444 Fax: 203-662-9445 |
Dr. Timothy M. Manoni, M.D. Surgery - Vascular Surgery Medicare: Accepting Medicare Assignments Practice Location: 85 Old Kings Hwy N, Darien, CT 06820 Phone: 203-210-6333 Fax: 203-502-2615 |
Dr. Taras V. Kucher, M.D. Surgery - Vascular Surgery Medicare: Accepting Medicare Assignments Practice Location: 85 Old Kings Hwy N, Darien, CT 06820 Phone: 203-210-6333 Fax: 203-502-2615 |
Paul Gagne, M.D. Surgery - Vascular Surgery Medicare: Accepting Medicare Assignments Practice Location: 330 Boston Post Rd Ste 240, Darien, CT 06820 Phone: 203-548-7858 Fax: 203-439-4839 |
News Archive
Chances are you've heard of or even taken probiotics: supplements delivering "good microbes" to the gut, providing a wide range of health benefits. If you're really up on your gut health, you may also be aware of prebiotics: supplements designed to fuel the good microbes already living in our guts.
It had previously been thought that the drug works by preventing cells in the intestine from absorbing cholesterol. The new research suggests that Zetia also works in the liver.
Many academic researchers and pharmaceutical companies have identified new Alzheimer's drug therapy candidates, but lack the funding to move them into human testing. At the same time, few funding sources support early-phase clinical drug trials. As a result, too many promising studies stall out early in the discovery process.
Kohlberg Kravis Roberts & Co. L.P. (together with its affiliates, "KKR") and funds advised by Permira announce that Lavena Holding 5 GmbH, the holding company held jointly by KKR and the Permira Funds, is intending to sell in the market a total of 8 million preference shares, representing approximately 3.7% of the total share capital of ProSiebenSat.1 Media AG ("P7S1"), by way of an accelerated book building to institutional investors.
› Verified 5 days ago